Breathlessness, also known as dyspnoea, is a debilitating and frequent symptom. Several reports have highlighted the lack of dyspnoea in a subgroup of patients suffering from COVID-19, sometimes referred to as “silent” or “happy hyp-oxaemia.” Reports have also mentioned the absence of a clear relationship between the clinical severity of the disease and levels of breathlessness reported by patients. The cerebral complications of COVID-19 have been largely demonstrated with a high prevalence of an acute encephalopathy that could possibly affect the processing of afferent signals or top-down modulation of breathlessness signals. In this review, we aim to highlight the mechanisms involved in breathlessness and summarize the pathophysiology of COVID-19 and its known effects on the brain-lung interaction. We then offer hypotheses for the alteration of breathlessness perception in COVID-19 patients and suggest ways of further researching this phenomenon.

1.
Parshall
MB
,
Schwartzstein
RM
,
Adams
L
,
Banzett
RB
,
Manning
HL
,
Bourbeau
J
,
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea
.
Am J Respir Crit Care Med
.
2012 Feb 15
;
185
(
4
):
435
52
. .
2.
Zhu
Z
,
Lian
X
,
Su
X
,
Wu
W
,
Marraro
GA
,
Zeng
Y
.
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
.
Respir Res
.
2020 Aug 27
;
21
(
1
):
224
. .
3.
Guan
WJ
,
Ni
ZY
,
Hu
Y
,
Liang
WH
,
Ou
CQ
,
He
JX
,
Clinical characteristics of coronavirus disease 2019 in China
.
N Engl J Med
.
2020 30
;
382
(
18
):
1708
20
. .
4.
Chen
L
,
Liu
HG
,
Liu
W
,
Liu
J
,
Liu
K
,
Shang
J
,
Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia
.
Zhonghua Jie He He Hu Xi Za Zhi
.
2020 Feb 6
;
43
(
0
):
E005
. .
5.
Rodriguez-Morales
AJ
,
Cardona-Ospina
JA
,
Gutiérrez-Ocampo
E
,
Villamizar-Peña
R
,
Holguin-Rivera
Y
,
Escalera-Antezana
JP
,
Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis
.
Travel Med Infect Dis
.
2020 Mar
;
34
:
101623
. .
6.
Li
LQ
,
Huang
T
,
Wang
YQ
,
Wang
ZP
,
Liang
Y
,
Huang
TB
,
COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis
.
J Med Virol
.
2020
;
92
(
6
):
577
83
. .
7.
Huang
C
,
Wang
Y
,
Li
X
,
Ren
L
,
Zhao
J
,
Hu
Y
,
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
.
Lancet Lond Engl
.
2020 15
;
395
(
10223
):
497
506
.
8.
Hu
Y
,
Sun
J
,
Dai
Z
,
Deng
H
,
Li
X
,
Huang
Q
,
Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis
.
J Clin Virol
.
2020
;
127
:
104371
. .
9.
Chen
N
,
Zhou
M
,
Dong
X
,
Qu
J
,
Gong
F
,
Han
Y
,
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
.
Lancet
.
2020 15
;
395
(
10223
):
507
13
. .
10.
Shi
L
,
Wang
Y
,
Wang
Y
,
Duan
G
,
Yang
H
.
Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19
.
J Infect
.
2020 May 15
;
81
:
647
79
.
11.
Tobin
MJ
,
Laghi
F
,
Jubran
A
.
Why COVID-19 silent hypoxemia is baffling to physicians
.
Am J Respir Crit Care Med
.
2020 Aug 1
;
202
(
3
):
356
60
. .
12.
Li
YC
,
Bai
WZ
,
Hashikawa
T
.
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
.
J Med Virol
.
2020 Feb 27
;
92
:
552
55
.
13.
Coen
M
,
Allali
G
,
Adler
D
,
Serratrice
J
.
Hypoxemia in COVID-19; Comment on: The neuroinvasive potential of SARS–CoV2 may play a role in the respiratory failure of COVID-19 patients
.
J Med Virol
.
2020 May 17
;
92
:
1705
6
.
14.
Dhont
S
,
Derom
E
,
Van Braeckel
E
,
Depuydt
P
,
Lambrecht
BN
.
The pathophysiology of ‘happy’ hypoxemia in COVID-19
.
Respir Res
.
2020 Jul 28
;
21
(
1
):
198
. .
15.
Das
G
,
Mukherjee
N
,
Ghosh
S
.
Neurological Insights of COVID-19 Pandemic
.
ACS Chem Neurosci
.
2020 06
;
11
(
9
):
1206
9
. .
16.
Manning
HL
,
Schwartzstein
RM
.
Pathophysiology of dyspnea. Epstein FH, editor
.
N Engl J Med
.
1995 Dec 7
;
333
(
23
):
1547
53
.
17.
Lansing
RW
,
Gracely
RH
,
Banzett
RB
.
The multiple dimensions of dyspnea: review and hypotheses
.
Respir Physiol Neurobiol
.
2009 May 30
;
167
(
1
):
53
60
. .
18.
Schön
D
,
Rosenkranz
M
,
Regelsberger
J
,
Dahme
B
,
Büchel
C
,
von Leupoldt
A
.
Reduced perception of dyspnea and pain after right insular cortex lesions
.
Am J Respir Crit Care Med
.
2008 Dec
;
178
(
11
):
1173
9
. .
19.
Banzett
RB
.
Dyspnea and pain: similarities and constrasts between two very unpleasant sensations
.
APS Bull
.
2001
;
11
(
1
).
20.
von Leupoldt
A
,
Sommer
T
,
Kegat
S
,
Baumann
HJ
,
Klose
H
,
Dahme
B
,
The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala
.
Am J Respir Crit Care Med
.
2008 May 1
;
177
(
9
):
1026
32
. .
21.
González-Duarte
A
,
Norcliffe-Kaufmann
L
.
Is “happy hypoxia” in COVID-19 a disorder of autonomic interoception? A hypothesis
.
Clin Auton Res Off J Clin Auton Res Soc
.
2020
;
30
(
4
):
331
3
.
22.
Currow
DC
,
Higginson
IJ
,
Johnson
MJ
.
Breathlessness–current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop
.
Palliat Med
.
2013 Dec
;
27
(
10
):
932
8
. .
23.
Spathis
A
,
Booth
S
,
Moffat
C
,
Hurst
R
,
Ryan
R
,
Chin
C
,
The breathing, thinking, functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease
.
NPJ Prim Care Respir Med
.
2017 Apr 21
;
27
(
1
):
27
. .
24.
Chin
C
,
Booth
S
.
Managing breathlessness: a palliative care approach
.
Postgrad Med J
.
2016 Jul
;
92
(
1089
):
393
400
. .
25.
Carpio
C
,
Villasante
C
,
Galera
R
,
Romero
D
,
de Cos
A
,
Hernanz
A
,
Systemic inflammation and higher perception of dyspnea mimicking asthma in obese subjects
.
J Allergy Clin Immunol
.
2016 Mar
;
137
(
3
):
718
26.e4
. .
26.
Scioscia
G
,
Blanco
I
,
Arismendi
E
,
Burgos
F
,
Gistau
C
,
Foschino Barbaro
MP
,
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
.
Thorax
.
2017 Feb
;
72
(
2
):
117
21
. .
27.
Petersen
S
,
von Leupoldt
A
,
Van den Bergh
O
.
Geriatric dyspnea: doing worse, feeling better
.
Ageing Res Rev
.
2014 May
;
15
:
94
9
. .
28.
von Leupoldt
A
,
Dahme
B
.
Cortical substrates for the perception of dyspnea
.
Chest
.
2005 Jul
;
128
(
1
):
345
54
. .
29.
von Leupoldt
A
,
Ambruzsova
R
,
Nordmeyer
S
,
Jeske
N
,
Dahme
B
.
Sensory and affective aspects of dyspnea contribute differentially to the Borg scale’s measurement of dyspnea
.
Respiration
.
2006
;
73
(
6
):
762
8
. .
30.
von Leupoldt
A
,
Mertz
C
,
Kegat
S
,
Burmester
S
,
Dahme
B
.
The impact of emotions on the sensory and affective dimension of perceived dyspnea
.
Psychophysiology
.
2006 Jul
;
43
(
4
):
382
6
. .
31.
Janssen
DJ
,
Wouters
EF
,
Spruit
MA
.
Psychosocial consequences of living with breathlessness due to advanced disease
.
Curr Opin Support Palliat Care
.
2015 Sep
;
9
(
3
):
232
7
. .
32.
Di Giulio
C
.
Ageing of the carotid body
.
J Physiol
.
2018
;
596
(
15
):
3021
7
. .
33.
Kronenberg
RS
,
Drage
CW
.
Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men
.
J Clin Invest
.
1973 Aug
;
52
(
8
):
1812
9
. .
34.
Janssens
JP
,
Pache
JC
,
Nicod
LP
.
Physiological changes in respiratory function associated with ageing
.
Eur Respir J
.
1999 Jan
;
13
(
1
):
197
205
. .
35.
Singh
AK
,
Gupta
R
,
Ghosh
A
,
Misra
A
.
Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations
.
Diabetes Metab Syndr
.
2020 Apr 9
;
14
(
4
):
303
10
. .
36.
Riddle
MC
,
Buse
JB
,
Franks
PW
,
Knowler
WC
,
Ratner
RE
,
Selvin
E
,
COVID-19 in people with diabetes: urgently needed lessons from early reports
.
Diabetes Care
.
2020 May 14
;
43
:
1378
81
.
37.
Gupta
R
,
Hussain
A
,
Misra
A
.
Diabetes and COVID-19: evidence, current status and unanswered research questions
.
Eur J Clin Nutr
.
2020 May 13
;
74
:
864
70
.
38.
Yan
Y
,
Yang
Y
,
Wang
F
,
Ren
H
,
Zhang
S
,
Shi
X
,
Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes
.
BMJ Open Diabetes Res Care
.
2020
;
8
(
1
):
e001343
. .
39.
Wang
CP
,
Lorenzo
C
,
Espinoza
SE
.
Frailty attenuates the impact of metformin on reducing mortality in older adults with type 2 diabetes
.
J Endocrinol Diabetes Obes
.
2014
;
2
(
2
):
1031
.
40.
Muniyappa
R
,
Gubbi
S
.
COVID-19 pandemic, coronaviruses, and diabetes mellitus
.
Am J Physiol Endocrinol Metab
.
2020 01
;
318
(
5
):
E736
41
. .
41.
Kolahian
S
,
Leiss
V
,
Nürnberg
B
.
Diabetic lung disease: fact or fiction?
Rev Endocr Metab Disord
.
2019
;
20
(
3
):
303
19
. .
42.
Weynand
B
,
Jonckheere
A
,
Frans
A
,
Rahier
J
.
Diabetes mellitus induces a thickening of the pulmonary basal lamina
.
Respiration
.
1999
;
66
(
1
):
14
9
. .
43.
Rothan
HA
,
Byrareddy
SN
.
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
.
J Autoimmun
.
2020
;
109
:
102433
. .
44.
Niu
S
,
Tian
S
,
Lou
J
,
Kang
X
,
Zhang
L
,
Lian
H
,
Clinical characteristics of older patients infected with COVID-19: a descriptive study
.
Arch Gerontol Geriatr
.
2020 Apr 10
;
89
:
104058
. .
45.
Tian
W
,
Jiang
W
,
Yao
J
,
Nicholson
CJ
,
Li
RH
,
Sigurslid
HH
,
Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis
.
J Med Virol
.
2020 May 22
;
92
:
1875
83
.
46.
Gattinoni
L
,
Chiumello
D
,
Caironi
P
,
Busana
M
,
Romitti
F
,
Brazzi
L
,
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Intensive Care Med
.
2020
;
46
(
6
):
1099
102
. .
47.
Menter
T
,
Haslbauer
JD
,
Nienhold
R
,
Savic
S
,
Hopfer
H
,
Deigendesch
N
,
Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction
.
Histopathology
.
2020 May 4
;
77
:
198
209
.
48.
Carsana
L
,
Sonzogni
A
,
Nasr
A
,
Rossi
R
,
Pellegrinelli
A
,
Zerbi
P
,
Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy
.
Lancet Infect Dis
.
2020
;
20
:
1135
1140
.
49.
Ward
J
.
Physiology of breathing II
.
Surgery
.
2005 Dec
;
23
(
12
):
430
5
. .
50.
West
JB
,
Luks
A
.
West’s respiratory physiology: the essentials
. 10th ed.
Philadelphia, PA
:
Wolters Kluwer
;
2016
. p.
238
.
51.
Lechien
JR
,
Chiesa-Estomba
CM
,
Place
S
,
Van Laethem
Y
,
Cabaraux
P
,
Mat
Q
,
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019
.
J Intern Med
.
2020 Apr 30
;
288
:
335
44
.
52.
Magro
C
,
Mulvey
JJ
,
Berlin
D
,
Nuovo
G
,
Salvatore
S
,
Harp
J
,
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
.
Transl Res J Lab Clin Med
.
2020 Apr 15
;
220
:
1
13
.
53.
Ciceri
F
,
Beretta
L
,
Scandroglio
AM
,
Colombo
S
,
Landoni
G
,
Ruggeri
A
,
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
.
Crit Care Resusc
.
2020 Apr 15
;
22
:
95
7
.
54.
Lodigiani
C
,
Iapichino
G
,
Carenzo
L
,
Cecconi
M
,
Ferrazzi
P
,
Sebastian
T
,
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
.
Thromb Res
.
2020
;
191
:
9
14
.
55.
Middeldorp
S
,
Coppens
M
,
van Haaps
TF
,
Foppen
M
,
Vlaar
AP
,
Müller
MCA
,
Incidence of venous thromboembolism in hospitalized patients with COVID-19
.
J Thromb Haemost
.
2020 May 5
;
18
:
1995
2002
.
56.
Connors
JM
,
Levy
JH
.
COVID-19 and its implications for thrombosis and anticoagulation
.
Blood
.
2020 Jun 4
;
135
(
23
):
2033
40
. .
57.
Spiezia
L
,
Boscolo
A
,
Poletto
F
,
Cerruti
L
,
Tiberio
I
,
Campello
E
,
COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure
.
Thromb Haemost
.
2020 Jun
;
120
(
6
):
998
1000
. .
58.
Giannis
D
,
Ziogas
IA
,
Gianni
P
.
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
.
J Clin Virol
.
2020 Jun
;
127
:
104362
. .
59.
Lai
CC
,
Shih
TP
,
Ko
WC
,
Tang
HJ
,
Hsueh
PR
.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges
.
Int J Antimicrob Agents
.
2020 Mar
;
55
(
3
):
105924
. .
60.
Li
K
,
Wohlford-Lenane
C
,
Perlman
S
,
Zhao
J
,
Jewell
AK
,
Reznikov
LR
,
Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4
.
J Infect Dis
.
2016 Mar 1
;
213
(
5
):
712
22
. .
61.
Baig
AM
,
Khaleeq
A
,
Ali
U
,
Syeda
H
.
Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms
.
ACS Chem Neurosci
.
2020 01
;
11
(
7
):
995
8
. .
62.
Puelles
VG
,
Lütgehetmann
M
,
Lindenmeyer
MT
,
Sperhake
JP
,
Wong
MN
,
Allweiss
L
,
Multiorgan and renal tropism of SARS-CoV-2
.
N Engl J Med
.
2020 May 13
;
383
:
590
92
.
63.
Matschke
J
,
Lütgehetmann
M
,
Hagel
C
,
Sperhake
JP
,
Schröder
AS
,
Edler
C
,
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
.
Lancet Neurol
.
2020 Nov
;
19
(
11
):
919
29
.
64.
Baig
AM
.
Neurological manifestations in COVID-19 caused by SARS-CoV-2
.
CNS Neurosci Ther
.
2020
;
26
(
5
):
499
501
. .
65.
Butowt
R
,
Bilinska
K
.
SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection
.
ACS Chem Neurosci
.
2020 06
;
11
(
9
):
1200
3
. .
66.
Paybast
S
,
Emami
A
,
Koosha
M
,
Baghalha
F
.
Novel coronavirus disease (COVID-19) and central nervous system complications: what neurologist need to know
.
Acta Neurol Taiwan
.
2020 Mar 30
;
29(1)
(
1
):
24
31
.
67.
Marinho
PM
,
Marcos
AAA
,
Romano
AC
,
Nascimento
H
,
Belfort
R
.
Retinal findings in patients with COVID-19
.
Lancet
.
2020 23
;
395
(
10237
):
1610
. .
68.
Lovell
N
,
Maddocks
M
,
Etkind
SN
,
Taylor
K
,
Carey
I
,
Vora
V
,
Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care
.
J Pain Symptom Manage
.
2020 Apr 20
;
60
:
e77
81
.
69.
Mao
L
,
Jin
H
,
Wang
M
,
Hu
Y
,
Chen
S
,
He
Q
,
Neurologic Manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
.
JAMA Neurol
.
2020 Apr 10
;
77
:
683
90
.
70.
O’Hanlon
S
,
Inouye
SK
.
Delirium: a missing piece in the COVID-19 pandemic puzzle
.
Age Ageing
.
2020 May 6
;
49
:
497
98
.
71.
Helms
J
,
Kremer
S
,
Merdji
H
,
Clere-Jehl
R
,
Schenck
M
,
Kummerlen
C
,
Neurologic features in severe SARS-CoV-2 infection
.
N Engl J Med
.
2020 04
;
382
(
23
):
2268
70
. .
72.
Garcez
FB
,
Aliberti
MJR
,
Poco
PCE
,
Hiratsuka
M
,
Takahashi
Sde F
,
Coelho
VA
,
Delirium and adverse outcomes in hospitalized patients with COVID-19
.
J Am Geriatr Soc
.
2020 Aug 24
;
68
:
2440
6
.
73.
Marengoni
A
,
Zucchelli
A
,
Grande
G
,
Fratiglioni
L
,
Rizzuto
D
.
The impact of delirium on outcomes for older adults hospitalised with COVID-19
.
Age Ageing
.
2020 Aug 20
;
49
:
923
6
.
74.
Mendes
A
,
Serratrice
C
,
Herrmann
FR
,
Genton
L
,
Périvier
S
,
Scheffler
M
,
Predictors of in-hospital mortality in older patients With COVID-19: the COVID age study
.
J Am Med Dir Assoc
.
2020 Nov
;
21
(
11
):
1546
1554.e3
. .
75.
Rogers
JP
,
Chesney
E
,
Oliver
D
,
Pollak
TA
,
McGuire
P
,
Fusar-Poli
P
,
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
.
Lancet Psychiatry
.
2020 May 18
;
7
:
611
27
.
76.
Koralnik
IJ
,
Tyler
KL
.
COVID-19: a global threat to the nervous system
.
Ann Neurol
.
2020
;
88
(
1
):
1
11
. .
77.
Pilotto
A
,
Odolini
S
,
Masciocchi
S
,
Comelli
A
,
Volonghi
I
,
Gazzina
S
,
Steroid-responsive encephalitis in coronavirus disease 2019
.
Ann Neurol
.
2020 May 17
;
88
:
423
7
.
78.
Pugin
D
,
Vargas
MI
,
Thieffry
C
,
Schibler
M
,
Grosgurin
O
,
Pugin
J
,
COVID-19-related encephalopathy responsive to high-dose glucocorticoids
.
Neurology
.
2020 22
;
95
(
12
):
543
6
. .
79.
Bernard-Valnet
R
,
Pizzarotti
B
,
Anichini
A
,
Demars
Y
,
Russo
E
,
Schmidhauser
M
,
Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection
.
Eur J Neurol
.
2020 May 7
;
27
:
e43
4
.
80.
Lechien
JR
,
Chiesa-Estomba
CM
,
De Siati
DR
,
Horoi
M
,
Le Bon
SD
,
Rodriguez
A
,
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
.
Eur Arch Otorhinolaryngol
.
2020 Aug
;
277
(
8
):
2251
61
. .
81.
Wang
D
,
Hu
B
,
Hu
C
,
Zhu
F
,
Liu
X
,
Zhang
J
,
Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China
.
JAMA
.
2020 Feb 7
;
323
:
1061
9
.
82.
Zhu
J
,
Zhong
Z
,
Ji
P
,
Li
H
,
Li
B
,
Pang
J
,
Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis
.
Fam Med Community Health
.
2020
;
8
(
2
):
e000406
. .
83.
Román
GC
,
Spencer
PS
,
Reis
J
,
Buguet
A
,
Faris
MEA
,
Katrak
SM
,
The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries
.
J Neurol Sci
.
2020 15
;
414
:
116884
. .
84.
Feinstein
JS
,
Buzza
C
,
Hurlemann
R
,
Follmer
RL
,
Dahdaleh
NS
,
Coryell
WH
,
Fear and panic in humans with bilateral amygdala damage
.
Nat Neurosci
.
2013 Mar
;
16
(
3
):
270
2
. .
85.
Zheng
Z
,
Peng
F
,
Xu
B
,
Zhao
J
,
Liu
H
,
Peng
J
,
Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis
.
J Infect
.
2020 Apr 23
;
81
(
2
):
e16
25
.
86.
Johnson
MJ
,
Close
L
,
Gillon
SC
,
Molassiotis
A
,
Lee
PH
,
Farquhar
MC
,
Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis
.
Eur Respir J
.
2016 Jun
;
47
(
6
):
1861
4
. .
87.
Tobin
MJ
.
Dyspnea. Pathophysiologic basis, clinical presentation, and management
.
Arch Intern Med
.
1990 Aug
;
150
(
8
):
1604
13
. .
88.
Kamal
M
,
Abo Omirah
M
,
Hussein
A
,
Saeed
H
.
Assessment and characterisation of post-COVID-19 manifestations
.
Int J Clin Pract
.
2020 Nov 3
;
75
:
e13746
.
89.
Carfì
A
,
Bernabei
R
,
Landi
F
;
Gemelli Against COVID-19 Post-Acute Care Study Group
.
Persistent symptoms in patients after acute COVID-19
.
JAMA
.
2020 Aug 11
;
324
(
6
):
603
5
.
90.
Versace
V
,
Sebastianelli
L
,
Ferrazzoli
D
,
Romanello
R
,
Ortelli
P
,
Saltuari
L
,
Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19
.
Clin Neurophysiol
.
2021 May
;
132
(
5
):
1138
43
. .
91.
Wostyn
P
.
COVID-19 and chronic fatigue syndrome: is the worst yet to come?
Med Hypotheses
.
2021 Jan
;
146
:
110469
. .
92.
Ortelli
P
,
Ferrazzoli
D
,
Sebastianelli
L
,
Engl
M
,
Romanello
R
,
Nardone
R
,
Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom
.
J Neurol Sci
.
2021 Jan
;
420
:
117271
. .
93.
Clauw
DJ
,
Häuser
W
,
Cohen
SP
,
Fitzcharles
MA
.
Considering the potential for an increase in chronic pain after the COVID-19 pandemic
.
Pain
.
2020 Jun 26
;
161
:
1694
7
.
94.
Shiers
S
,
Ray
PR
,
Wangzhou
A
,
Sankaranarayanan
I
,
Tatsui
CE
,
Rhines
LD
,
ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects
.
Pain
.
2020
;
161
(
11
):
2494
501
. .
95.
Coen
M
,
Kaiser
C
,
Naimi
R
,
Uginet
M
,
Hentsch
L
,
Serratrice
J
,
Beyond silent hypoxemia: does COVID-19 can blunt pain perception? Comment on The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients
.
J Med Virol
.
2021 Apr
;
93
(
4
):
1915
6
.
96.
Moutal
A
,
Martin
LF
,
Boinon
L
,
Gomez
K
,
Ran
D
,
Zhou
Y
,
SARS-CoV-2 spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
.
Pain
.
2020 Oct 1
;
162
:
243
52
.
97.
Bausewein
C
,
Farquhar
M
,
Booth
S
,
Gysels
M
,
Higginson
IJ
.
Measurement of breathlessness in advanced disease: a systematic review
.
Respir Med
.
2007 Mar
;
101
(
3
):
399
410
. .
98.
Yorke
J
,
Moosavi
SH
,
Shuldham
C
,
Jones
PW
.
Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
.
Thorax
.
2010 Jan
;
65
(
1
):
21
6
. .
99.
Tan
JY
,
Yorke
J
,
Harle
A
,
Smith
J
,
Blackhall
F
,
Pilling
M
,
Assessment of breathlessness in lung cancer: psychometric properties of the Dyspnea-12 questionnaire
.
J Pain Symptom Manage
.
2017 Feb
;
53
(
2
):
208
15
. .
100.
Guyatt
GH
,
Berman
LB
,
Townsend
M
,
Pugsley
SO
,
Chambers
LW
.
A measure of quality of life for clinical trials in chronic lung disease
.
Thorax
.
1987 Oct
;
42
(
10
):
773
8
. .
101.
Johnson
MJ
,
Oxberry
SG
,
Cleland
JG
,
Clark
AL
.
Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review
.
Eur J Heart Fail
.
2010 Feb
;
12
(
2
):
137
47
. .
102.
Banzett
RB
,
Moosavi
SH
.
Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding
.
Eur Respir J
.
2017 Mar
;
49
(
3
):
1602473
. .
103.
Campbell
ML
.
Psychometric testing of a respiratory distress observation scale
.
J Palliat Med
.
2008 Feb
;
11
(
1
):
44
50
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.